Anthem to drop Meridian Health Services from Medicaid network
Anthem is set to remove Meridian Health Services from its Medicaid provider network in Indiana, effective October 1, 2026. This decision impacts tens ...
Anthem is set to remove Meridian Health Services from its Medicaid provider network in Indiana, effective October 1, 2026. This decision impacts tens ...
Carelon, Elevance Health's integrated care segment, is critical to the company's long-term growth by expanding beyond traditional health insurance. It...
Bearish
Elevance Health has paid the Centers for Medicare & Medicaid Services (CMS) $342 million. This payment comes amidst an ongoing Medicare Advantage prob...
A new study by the Elevance Health Public Policy Institute found that arbitration awards for certain planned medical procedures under the No Surprises...
Bullish
CNSide Diagnostics, a subsidiary of Plus Therapeutics, has secured a national agreement with Elevance Health to provide its CNSide Cerebrospinal Fluid...
Thomas Carr Howe Middle School has unveiled a new fitness and strength training space, created through a partnership with Elevance Health and the Impa...
Neutral
Hsbc Holdings PLC decreased its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 0.7% during the fourth quarter, according to its ...
Bullish
Elevance Health has invested $640 million in affordable housing over the last five years, bringing its total commitment to over $1 billion for more th...
Elevance Health is introducing new programs and digital tools like Total Movement Care and Sydney Health to help adults manage chronic conditions more...
Elevance Health director Robert L. Dixon Jr. reported an open-market sale of 151 shares of common stock at $401.77 per share on June 11, 2026. Followi...
Elevance Health (ELV) has reaffirmed its 2026 adjusted EPS guidance, expecting at least $26.75 per share. This figure is slightly below the FactSet es...
Analysts have raised the average 12-month price target for Elevance Health, Inc. stock from $402.71 to $406.38, suggesting a 4% upside from its recent...
The average 12-month price target for Elevance Health, Inc. (ELV) stock has been raised to $405.19 by 21 analysts, up from $402.71. This new target su...